What are the latest Philips and ResMed CPAP machine recalls in 2023 – 2025?

Written by:

Updated:

Table of Contents
Add to cart
Add to cart
Add to cart

Liked this post? Share with others!

In Canada, the topic of CPAP machine recalls has remained at the forefront of sleep health conversations since the original Philips recall shook the market in 2021. Fast-forward to 2023–2025, and Canadians continue to navigate a complicated recall environment, especially if they use equipment from major brands like Philips or ResMed. But what exactly has happened in the last few years, and where do Canadian users stand now?

Let’s break it down clearly — starting with what was recalled, why it was recalled, and how Health Canada responded. For reference, you can review official recall information via Health Canada’s Recalls and Safety Alerts and the U.S. FDA Medical Device Recall Database.

CPAP Machines Recall

Philips Recall: 2023 – 2025 Developments

The Philips CPAP recall started in 2021, but updates through 2023–2025 have significantly altered the scope and severity of the issue in Canada.

The primary concern involves the degradation of PE-PUR sound abatement foam, which can disintegrate and release:

  • Toxic particles
  • Volatile organic compounds (VOCs)
  • Potentially carcinogenic chemicals

These materials may enter the airway and cause a range of symptoms, from headaches and cough to more severe respiratory or even carcinogenic concerns.

Key recall-related events in Canada (2023–2025):

  • In 2023, Health Canada expanded its safety bulletin to include more Philips devices, including specific batches of DreamStation Go and System One BiPAPs.
  • In 2024, new evidence pointed to ongoing foam degradation even in some repaired or replaced units, prompting Health Canada to reclassify the issue as a Type I recall.
  • By mid-2025, Philips acknowledged that some DreamStation 2 units may also be impacted and began voluntary replacements in both the U.S. and Canada.

ResMed: Limited Field Notices, Not Full Recalls

Unlike Philips, ResMed has not issued a formal product recall in Canada between 2023 and 2025. However, it’s important to note that:

  • A 2023 field safety notice was issued for specific AirSense 10 devices related to inaccurate pressure delivery due to internal valve wear.
  • This was not classed as a full recall by Health Canada, and no health risks from foam or chemicals were identified.
  • ResMed emphasized that affected units remained safe but encouraged users to check their serial numbers if experiencing inconsistent performance.

Despite the lower profile of these issues, it has led many users to become more cautious — especially given the growing scrutiny of respiratory equipment.

Health Canada’s Role: Increasing Oversight

Canadian regulators have taken a stronger stance since 2023. 

Health Canada:

  • Expanded mandatory recall classifications.
  • Strengthened reporting channels for patient complaints.
  • Coordinated directly with Philips and ResMed to ensure timely communication with patients and clinics.
  • Issued joint advisories with the U.S. FDA to warn about continuing risks.

For Canadians, this means greater transparency — but also a heightened need to remain informed about what’s happening.

The Rise of BeC CPAP Machines: A Recall-Free Alternative

Amid this climate of recalls and uncertainty, Canadian users are increasingly exploring BeC CPAP Machines as a safer, locally trusted alternative.

Here’s why:

  • BeC CPAP Machines have never been recalled in Canada or abroad.
  • They’re available at 20% lower prices than comparable Philips or ResMed models.
  • Every machine comes fully equipped — with mask, tubing, and filters included.
  • Machines are available for free in many provinces through insurance or sleep aid programs.

Why does this matter? Because while many Canadians are waiting months for replacement devices from Philips, BeC CPAP offers fast delivery and support, backed by a Canadian team.

If you’re concerned about your Philips or ResMed device — or simply ready to switch — BeC CPAP Machines provide a proven, cost-effective, and recall-free option for continued sleep apnea therapy. Just call +1 (855) 860-3404

Final Thoughts about CPAP Recall in 2025

The landscape of CPAP machine recalls is still evolving. Philips is still managing the fallout from earlier recalls, and while ResMed remains more stable, some Canadian users have lost confidence.

What’s the safest move? Stay informed. Register your device. Check recall notices often. And if you’re tired of waiting or worried about your current unit, consider BeC CPAP for uninterrupted, trusted therapy — right here in Canada.

Next: We’ll explore which specific Philips and ResMed models are under recall and what Canadian users should know about checking their machines.

BeC CPAP Machines as a ResMed and Philips Alternative — Never Had Recall

In a climate of uncertainty surrounding CPAP recalls, Canadian patients are searching for alternatives they can trust. While global brands like Philips and ResMed have dominated the market for years, the ongoing recall concerns — especially those tied to foam degradation and chemical exposure — have opened the door for safer, locally focused solutions. Enter BeC CPAP Machines: a Canadian alternative that has never been subject to a product recall and is rapidly becoming the go-to option for patients across Ontario and the rest of Canada.

Why Recall-Free Matters in CPAP Therapy

Let’s be honest: CPAP therapy is not optional for people living with sleep apnea. It’s a medical necessity. That’s why reliability and safety must come first. The Philips recall alone, first issued in 2021 and continuing with updates into 2025, has impacted over 15 million devices globally, including hundreds of thousands distributed across Canada.

The core issue? PE-PUR sound foam degradation, which can release potentially carcinogenic particles and gases into the patient’s airway.

Even ResMed, though not formally recalled in Canada, has issued field safety notices about device performance issues, including internal valve degradation. The message is clear: patients deserve better.

That’s where BeC CPAP Machines stand apart.

The BeC Advantage: Built for Canadians, By Canadians

Unlike global manufacturers whose recall strategies are managed out of the U.S. or Europe, BeC CPAP is a Canadian-first company. The devices are developed and distributed with full compliance to Health Canada guidelines.

That means:

  • No recall history to date (2021–2025).
  • Certified for use by Canadian sleep labs and respiratory therapists.
  • Supported by a Canadian customer service team based in Ontario.

When you’re dealing with a sleep disorder, the last thing you want is to question the safety of your equipment. BeC’s track record makes it an increasingly appealing option for Canadian households.

What Comes with a BeC CPAP Machine?

Many patients are surprised at how much value BeC offers, especially compared to bigger-name competitors.

Each BeC CPAP machine comes:

  • Fully equipped with a mask, tubing, and filters — no separate purchases required.
  • At a 20% lower cost on average than ResMed or Philips systems.
  • With free delivery across Canada.
  • Eligible for insurance coverage and provincial health assistance programs.

Whether you live in Toronto, Ottawa, Vancouver, or Halifax, BeC CPAP machines are available for quick order through Beccpap.ca, with bilingual support and expert follow-up.

“We switched to BeC after my Philips machine was recalled. The transition was smooth, and the difference in air quality is noticeable.” — Anna L., Mississauga, ON

For Clinics and Sleep Labs: A Reliable Partner

BeC isn’t just a great option for individual users — it’s also gaining traction in Canadian clinics. With ongoing shortages of replacement parts for Philips and long service queues for ResMed, BeC is quickly becoming the preferred partner for home testing programs and rental units.

BeC partners enjoy:

  • Faster unit availability.
  • Bulk ordering options.
  • Access to digital compliance data.
  • Dedicated clinic support lines.

Sleep professionals now recommend BeC CPAP as a first-line option for patients newly diagnosed with sleep apnea — not just as a recall backup.

Why Canadian Sleep Apnea Patients Are Making the Switch

Some common reasons people are switching from Philips and ResMed to BeC include:

  • Peace of mind: no history of recall.
  • Cost savings: no hidden fees or accessory charges.
  • Availability: machines and accessories in stock and ready to ship.
  • Customer service: support in English and French from a local team.

In uncertain times, certainty matters. BeC provides that certainty.

Final Word: Trust Starts with Safety

For too long, Canadian patients have relied on global CPAP brands that, while advanced, have shown vulnerabilities in safety and accountability. As more information surfaces about the long-term effects of inhaling foam particles or experiencing system failures, users are rightly re-evaluating their options.

BeC CPAP Machines offer a clean slate — recall-free, patient-focused, and built for Canadians. Calendly button

Which Philips or ResMed CPAP machines are currently under recall?

If you’re using a CPAP machine in Canada, especially from Philips or ResMed, it’s critical to know whether your device has been affected by a recall. Since the Philips recall first began in 2021, the list of impacted models has grown significantly, extending into 2025. While ResMed machines have not seen the same level of action, certain advisory notices have sparked concern among patients and clinicians alike.

This section offers a detailed, Canada-focused list of currently recalled or flagged CPAP, BiPAP, and ventilator machines from Philips and ResMed, alongside their status with Health Canada and manufacturer recommendations.

Philips CPAP and BiPAP Devices Under Recall (2021–2025)

As of 2025, Philips continues to manage one of the largest medical device recalls in history. The core issue remains the breakdown of PE-PUR foam, which can degrade and release harmful particles and gases into the user’s airway.

Here’s a breakdown of Philips machines currently under recall in Canada, based on Health Canada and FDA databases:

CPAP and BiLevel PAP Devices:

  • DreamStation CPAP, Auto CPAP, BiPAP (1st generation).
  • DreamStation Go Travel CPAP.
  • System One 50 Series CPAP and BiPAP.
  • System One 60 Series CPAP and BiPAP.
  • C-Series S/T, AVAPS.
  • Dorma 400 and Dorma 500 CPAP.
  • REMstar SE Auto CPAP.

Mechanical Ventilators (non-life-sustaining):

  • Trilogy 100 and Trilogy 200.
  • A-Series BiPAP A30 and A40 (specific versions).

Newly flagged models (2023–2025):

  • DreamStation 2 – Some serial numbers manufactured before September 2022 have been linked to foam odour and visible degradation, prompting Philips to begin voluntary replacement programs in Canada.

What Devices Are NOT Affected?

Philips has clarified that the following are not currently included in the recall:

  • DreamStation 2 units manufactured after September 1, 2022.
  • OmniLab Advanced Plus.
  • Trilogy Evo ventilators (except for separate battery-related concerns).

Still, it’s best to check your serial number on the official Philips Recall Portal to be sure.

ResMed CPAP Devices: No Recall, But Safety Notices

As of 2025, ResMed has not issued any formal CPAP recalls in Canada. However, that doesn’t mean all is quiet:

  • In late 2023, a field safety notice was issued for specific AirSense 10 models, alerting users to the possibility of internal air pressure valve deterioration, which may affect therapy effectiveness.
  • No chemical risks or foam degradation have been reported.
  • Health Canada did not classify this as a recall, but patients were advised to monitor machine performance and contact providers if issues occur.

How to Check If Your Device Is Recalled

Canadian users can use the following resources:

If you’re unsure or experience any symptoms like headaches, coughing, or dizziness while using your CPAP, consult your sleep specialist immediately.

What to Do If Your Machine Is Affected

If your Philips device is on the recall list:

  • Stop using it only if advised by your doctor.
  • Register it with the Philips Canada recall portal.
  • Request a replacement or repair (though wait times remain long in Canada).
  • Report health issues to Health Canada via the MedEffect reporting tool

Or, if you’re done waiting — consider a recall-free CPAP machine like those from BeC CPAP. All units are compliant with Canadian safety regulations and include mask, tubing, and filters.

Book a call with CPAP Expert right now

What symptoms are associated with recalled Philips CPAP machines?

Since the Philips CPAP recall began in 2021 and extended into 2025, thousands of users across Canada have reported a wide range of health symptoms linked to their use of affected devices. The recall was specifically issued due to the potential breakdown of the PE-PUR sound abatement foam, which can degrade over time and release harmful particles and chemical gases into the air pathway.

In this section, we’ll explore the reported symptoms, Health Canada’s findings, and what Canadian CPAP users need to monitor if they’ve used or are still using a recalled Philips device.

What Is PE-PUR Foam and Why Is It Dangerous?

PE-PUR (polyester-based polyurethane) foam was used in many Philips devices to reduce noise. However, under conditions of high heat and humidity, the foam can degrade.

This degradation can lead to:

  • Inhalation of microscopic particles.
  • Exposure to toxic chemical vapours, including toluene diisocyanate, dimethyl diazene, and formaldehyde-like compounds.

According to Health Canada’s classification, this poses both immediate and long-term health risks, including respiratory irritation and potential carcinogenic effects.

Short-Term Symptoms Reported by Canadian Users

Many Canadian patients who used recalled Philips CPAP machines have reported symptoms that emerged within days or weeks of regular use:

  • Coughing or throat irritation.
  • Dry mouth or airway inflammation.
  • Sinus infections or nasal congestion.
  • Headaches or migraines.
  • Fatigue unrelated to sleep quality.

These symptoms often overlap with those of untreated sleep apnea, making it difficult for some users to immediately identify the device as the cause.

“I thought I was just adjusting to my new mask, but the sore throat and coughing kept getting worse. It wasn’t until I read about the recall that I realized my DreamStation was part of it.” — James K., Calgary

Long-Term or Serious Health Concerns

Health Canada and the U.S. FDA have flagged more serious risks with long-term exposure to degraded foam particles and gases. These include:

  • Asthma-like symptoms or worsening of existing respiratory conditions
  • Chest tightness or shortness of breath
  • Persistent dizziness or confusion
  • Nausea and gastrointestinal distress
  • Lung inflammation (pneumonitis)
  • Potential cancer risks with prolonged exposure

Although direct causation has not been universally confirmed, animal studies cited by Philips and reviewed by the FDA show toxic effects in lung tissue with chronic exposure to PE-PUR degradation by-products.

Reports from Canadian Sleep Clinics

Several Canadian sleep clinics, including in Ontario, British Columbia, and Alberta, have reported clusters of patients presenting with these symptoms. Some clinics have urged patients to discontinue use of affected devices where alternatives like BeC CPAP Machines are available.

In a 2023 internal study by a Toronto-based sleep centre, 18% of patients using recalled Philips units reported persistent respiratory symptoms that improved once they switched devices.

What to Do If You’re Experiencing Symptoms

If you suspect your CPAP machine may be contributing to your symptoms:

  1. Stop using the device only after speaking with your doctor. Sleep apnea is a serious condition — abruptly stopping therapy can be dangerous.
  2. Check your device’s recall status.
  3. File a report with Health Canada through the MedEffect Adverse Reaction portal.
  4. Switch to a safer alternative, such as BeC CPAP Machines, which have no recall history and are compliant with Health Canada safety standards. Please provide a phone with opportunity to click 

Final Thought: Listen to Your Body

Many users ignored early symptoms, attributing them to allergies or dry winter air. But growing evidence in Canada points to a direct connection between degraded foam exposure and respiratory or neurological symptoms.

If something feels off — pay attention. Your device might be doing more harm than good.

Next: We’ll look specifically at whether ResMed CPAP machines are part of any current recall or advisory notice in Canada.

Are ResMed CPAP machines part of any current recall?

As of 2025, ResMed CPAP machines are not subject to any formal recalls in Canada. Unlike Philips, which has faced an ongoing recall crisis due to degrading PE-PUR foam, ResMed has maintained a stable safety record — at least officially. However, that doesn’t mean ResMed devices have been entirely without concern.

This section takes a clear, Canada-focused look at the status of ResMed machines, what notices have been issued, and what Canadian users should know.

ResMed’s Official Recall Record in Canada: 2023–2025

Note: No formal recalls have been issued by ResMed or mandated by Health Canada as of November 2025.

That said, in 2023, ResMed issued a field safety notice for a subset of its widely used AirSense 10 CPAP machines, warning about:

  • Internal valve degradation that could affect air pressure consistency.
  • Rare electrical faults in humidifier modules.

These were not linked to chemical exposure or foam breakdown like in the Philips case. Still, Health Canada monitored the situation and published a notice in its database under product advisories.

Which ResMed Models Have Been Flagged or Monitored?

Though none are formally recalled, the following models have been mentioned in various manufacturer communications or field notices:

  • AirSense 10 (Elite, AutoSet) – some units showed pressure delivery inconsistencies due to wear of internal parts.
  • AirCurve 10 – no structural safety issues, but firmware updates were recommended.
  • AirMini – some online discussions referenced condensation damage, but these remain anecdotal; no official action was taken.

Health Canada has not issued any Class I, II, or III recall designations for these units.

You can check ResMed advisories through your CPAP supplier or the ResMed Canada website.

Patient Concerns: What Canadian Users Have Reported

Although there is no widespread medical device recall, some Canadian patients have reported:

  • Noise fluctuations and inconsistent airflow.
  • Error codes related to humidifier components.
  • Increased dryness or nasal congestion not previously experienced.

It’s worth noting that these reports are often tied to machine age or lack of maintenance, rather than a systemic safety failure.

“My AirSense 10 started delivering uneven pressure after four years of use. It turned out to be the internal valve, which my clinic replaced quickly.” — Derek M., Ottawa

Should ResMed Users Be Concerned?

In short: Not at this time, according to Health Canada.

However, the 2023 field safety notice demonstrated that even trusted brands must continuously monitor performance. ResMed has committed to regular firmware updates and device checks, especially for older AirSense 10 units distributed before 2020.

If you’re unsure about your unit:

  • Contact your supplier for a device performance check.
  • Check your serial number via ResMed Canada.
  • Request maintenance or replacement options if your unit is more than five years old.

BeC CPAP Machines: A Stable, Recall-Free Option

If you’re looking for an option with zero recall history and strong Canadian support, consider switching to a BeC CPAP Machine:

Final Word

While ResMed continues to be considered safe, it’s essential for patients to stay updated. Even in the absence of recalls, field safety notices and patient reports serve as important reminders to monitor your machine’s performance and know your alternatives.

Next, we’ll explain how to check if your CPAP machine has been recalled, whether it’s from Philips, ResMed, or another brand.

How can I find out if my CPAP machine has been recalled?

If you’re using a CPAP, BiPAP, or ventilator machine in Canada and you’re unsure whether it’s affected by a recall, you’re not alone. With high-profile recalls — particularly those involving Philips Respironics devices — many Canadians are left wondering if their equipment is still safe.

This section provides a step-by-step guide tailored to Canadian users to help determine if your CPAP machine has been recalled, and what actions to take next.

Step 1: Identify Your Machine’s Brand, Model, and Serial Number

Before you can check recall status, you’ll need to gather the following information from your device:

  • Brand (e.g., Philips, ResMed)
  • Model name (e.g., DreamStation 1, AirSense 10, System One)
  • Serial number — usually located on the back or bottom of the device

Take note of any production or manufacturing dates on the label as well. These details are often required to verify recall eligibility.

Step 2: Use Official Recall Lookup Tools

For Philips Devices:

Visit the official Philips Recall Portal.

Here, you can:

  • Enter your serial number to check recall status
  • Register your device if it qualifies
  • Request a replacement or repair (note: wait times in Canada may be long)

For Canadian Recalls Generally:

Use the Health Canada Recalls and Safety Alerts Database:

This resource allows you to:

  • Search by product category or manufacturer
  • See all devices recalled in Canada, not just CPAP machines
  • Sign up for alerts on future updates

Step 3: Contact Your CPAP Supplier or Clinic

If you’re unsure about your device’s status, your local supplier or sleep clinic is often the fastest way to verify:

  • They may have access to batch-specific recall notices
  • Many offer on-site inspections of devices
  • Some can issue loaner machines if yours is affected

CTA: For example, clinics working with BeC CPAP often help patients confirm their device’s status and offer a safe, immediate replacement if needed.

Step 4: Watch for Symptoms or Performance Issues

Even if your machine isn’t officially recalled, stay alert for signs of malfunction or chemical exposure:

  • Unusual smells (chemical or burning)
  • Device overheating
  • Airflow irregularities
  • New or worsening respiratory symptoms

If you notice any of these issues, consult your sleep specialist and stop using the device only if they advise it.

What About ResMed Machines?

As of 2025, ResMed machines have not been formally recalled in Canada. However, users should:

  • Check for field safety notices on the ResMed Canada site
  • Contact support if you have an AirSense 10 manufactured before 2020

What If My Device Is Recalled?

Here’s what to do if your device is listed as recalled:

  1. Register your device with the manufacturer (e.g., Philips portal)
  2. Request a repair or replacement
  3. Speak with your doctor before discontinuing use
  4. Consider alternatives like BeC CPAP Machines that are recall-free and fully equipped

BeC CPAP units are available across Canada with masks, tubing, and filters included, and are often more affordable than recalled brands.

Final Word

Knowing whether your CPAP machine is under recall could protect your health and help you avoid long-term risks. Thankfully, with proper tools and support, Canadian users can take control of the situation quickly.

Next: We’ll look at the latest update from the FDA and Philips about the ongoing CPAP recall situation.

What is the latest update from the FDA and Philips about the CPAP recall?

As of 2025, the ongoing CPAP recall involving Philips Respironics has reached a new phase, with important developments issued by both the U.S. Food and Drug Administration (FDA) and Philips itself. While the original recall dates back to June 2021, recent actions and findings continue to impact Canadian patients, especially those still using affected models.

In this section, we break down the most recent updates from both the FDA and Philips — with Canadian relevance — so CPAP users know where things stand and what actions may still be required.

FDA Classification Remains at Class I — The Most Serious Recall Level

In 2024 and reaffirmed in 2025, the FDA has maintained the recall’s Class I status, its most serious designation.

This level applies when there’s a reasonable chance that use of the device could cause:

  • Serious injury.
  • Permanent impairment.
  • Death.

The FDA has reiterated its concerns about the PE-PUR sound abatement foam used in many Philips machines. 

Testing showed that this foam could break down and release:

  • Toxic particles into the device’s airflow.
  • Volatile organic compounds (VOCs) that may be carcinogenic.

In a 2023 FDA report, testing confirmed that foam degradation could occur in a variety of environmental conditions — including normal household humidity — making previous assumptions about limited risk outdated.

Philips’ Response: Ongoing Repairs and Limited Replacements

Philips has continued its remediation efforts through 2025, with updates posted on its global and Canadian recall portals:

  • The company has repaired or replaced over 3 million devices globally, but delays remain in Canada.
  • DreamStation 2 devices are now under internal review after some units were found to emit odours, suggesting potential early-stage foam degradation.
  • Philips Canada has promised faster distribution of replacement units but acknowledges ongoing backlogs.

Users can still register their devices or check replacement status at: https://www.philipssrcupdate.expertinquiry.com/

Philips also released updated FAQs and user instructions in late 2024 regarding:

  • Cleaning and storage guidance for affected machines
  • Risks of continuing to use an unmodified device
  • Alternate device options for high-risk patients

Canadian Relevance: Health Canada Aligns With FDA Findings

Although the FDA drives global device regulation, Health Canada has supported and echoed many of the FDA’s conclusions, including:

  • Maintaining the recall’s Type I classification in the Canadian registry
  • Advising patients to speak with their physician before discontinuing use
  • Encouraging users to file adverse event reports through MedEffect Canada

Both agencies stress that patients should not stop CPAP therapy without consulting a healthcare provider, even if the device is under recall.

Ongoing Investigations and Reports

As of 2025, the FDA is still:

  • Conducting long-term toxicology assessments on exposure to degraded foam particles
  • Requesting more transparency and testing data from Philips regarding DreamStation 2 units
  • Coordinating with global partners, including Health Canada, to monitor incident reports

There have been multiple legal actions in the U.S., and Canadians affected by the recall may be eligible for class-action participation, depending on provincial rulings.

Summary: What Canadian Users Need to Know

  • The FDA has not lifted the Class I recall status as of 2025
  • Philips has made some progress, but Canadian users still face long wait times
  • DreamStation 2 devices may also face future action
  • Health Canada is actively monitoring and advises caution

If you’re still using a recalled Philips CPAP machine, it’s critical to check your registration status and speak with your provider about alternatives.

Explore a Safer Option

For many Canadians tired of waiting, BeC CPAP Machines provide a recall-free, fully equipped alternative:

  • No foam degradation risk
  • 20% more affordable than Philips models
  • Ready-to-ship across Canada with mask, tube, and filters included.

Next: We’ll break down what actions CPAP users should take if they own a recalled device.

What actions should CPAP users take if they own a recalled device?

For Canadians using CPAP therapy, discovering that your device is under recall — especially one involving health risks — can be unsettling. But acting quickly and methodically is key to maintaining your safety without interrupting your sleep apnea treatment. Whether you use a Philips Respironics machine or are monitoring advisories from ResMed, here’s what to do next.

Step 1: Confirm Your Device Is Recalled

Start by checking whether your device is part of the official recall.

You’ll need your device’s model number and serial number, usually located on a sticker on the bottom or back of the unit.

If your device is not listed, monitor for updates — some newer recalls, such as those for certain DreamStation 2 units, are still being assessed.

Step 2: Register the Recalled Device

If your machine is affected:

  • Register your device on the Philips Canada recall site to begin the replacement or repair process.
  • Save your registration confirmation — processing delays are common in Canada, and proof of registration can expedite support.
  • Some provincial health programs or insurance carriers may also request this proof.

Step 3: Speak to Your Sleep Specialist or Doctor

Do not stop using your CPAP machine without first consulting your sleep physician. Sleep apnea poses real health risks, and discontinuing treatment can lead to:

  • Increased fatigue and poor concentration.
  • Higher risk of cardiovascular events.
  • Worsening of other chronic conditions.

Your doctor can advise on whether it’s safer to continue using the device while awaiting a replacement or to seek an immediate alternative.

Step 4: Explore Safe, Recall-Free Alternatives

If your doctor recommends switching devices, you don’t have to wait months for Philips.

BeC CPAP Machines offer a proven alternative in Canada:

  • No recall history
  • Comes fully equipped with tubing, mask, and filters
  • Up to 20% more affordable than Philips or ResMed models
  • Available for quick delivery and covered by many insurance plans

You can order directly with the BeC CPAP shop online or ask your sleep clinic if they partner with BeC.

“Switching to BeC CPAP meant I could sleep peacefully without worrying about foam degradation or delivery delays. I received my unit in under a week.” — Linda G., Toronto

Step 5: Report Any Health Concerns

If you’ve experienced any symptoms potentially linked to your recalled CPAP device — such as:

  • Coughing
  • Throat irritation
  • Sinus issues
  • Dizziness or nausea

— it’s important to file a report with Health Canada’s MedEffect Program.

These reports help Health Canada evaluate the real-world risks associated with recalled devices.

Optional Step: Contact Your Supplier or Sleep Clinic

Some local CPAP providers offer:

  • Loaner machines
  • On-site evaluations of your recalled unit
  • Support with warranty or insurance claims

If you’re based in Ontario, BeC CPAP clinics can assist with same-day device assessments and transition plans.

Summary: Key Actions for Recalled Device Owners

  1. Confirm recall status via official websites.
  2. Register your device with Philips Canada.
  3. Consult your doctor before stopping therapy.
  4. Consider BeC CPAP for a fast, safe alternative.
  5. Report symptoms to Health Canada.
  6. Stay updated on new advisories or eligibility expansions.

Next: We’ll examine how the Philips DreamStation 2 is being affected by the recall process and what Canadian users are reporting so far.

What legal actions have been taken in the Philips CPAP recall lawsuit?

As the Philips CPAP recall continues to evolve, so too do the legal consequences — particularly in North America. While much of the early litigation activity originated in the United States, Canadian legal responses have begun to gain traction, offering possible avenues for financial and health-related compensation for affected users.

This section explores the legal actions related to the Philips recall, both in Canada and internationally, with a focus on what Canadian CPAP users need to know in 2025.

Background: Why Are There Lawsuits Against Philips?

The core issue stems from Philips’ use of PE-PUR (polyester-based polyurethane) foam in several of its CPAP, BiPAP, and ventilator devices. 

The foam was found to degrade over time, exposing users to potentially toxic particles and gases, including compounds linked to:

  • Respiratory irritation.
  • Neurological symptoms.
  • Potential cancer risk.

Users across North America allege that Philips was aware of these risks before issuing the recall in 2021 and failed to act swiftly, leaving patients vulnerable.

U.S. Class Action Lawsuits: A Precedent

In the United States, Philips has faced multiple class action lawsuits since 2021. Key legal developments include:

  • Consolidation of thousands of claims into multi-district litigation (MDL 3014) in federal court.
  • Allegations of negligence, product liability, and failure to warn.
  • Settlement negotiations underway as of mid-2025, with some early resolutions in favour of patients.

These U.S. cases are significant because they:

  • Set legal precedent
  • Pressure Philips into broader compensation frameworks
  • Support international plaintiffs by revealing internal company documentation

Legal Actions in Canada: What’s Happening?

In Canada, several class action lawsuits have been filed provincially, including in:

  • Ontario (Toronto-based firms leading several consolidated claims).
  • British Columbia.
  • Quebec.

As of 2025:

  • No national settlement has been finalized.
  • Cases remain in pre-trial or certification stages.
  • Plaintiffs are seeking compensation for:
    • Costs of replacement devices
    • Out-of-pocket health expenses
    • Physical and emotional harm

“This is about more than defective hardware. It’s about trust — and the health risks Canadian patients unknowingly faced.” — Legal counsel, Ontario Superior Court filing

Can Canadian Users Join the Lawsuit?

Yes, but it depends on the province.

To join or stay informed:

  • Contact a local class-action law firm involved in the CPAP litigation (e.g., in Toronto or Vancouver)
  • Ask your clinic or supplier if they’re aware of pending actions
  • Check provincial court websites for case updates

Note: You do not have to take legal action to get your device replaced, but doing so may offer compensation for related damages.

Government Involvement and Oversight

While Health Canada is not directly involved in lawsuits, it has been:

  • Monitoring patient complaints
  • Sharing safety data with international regulators
  • Encouraging Philips to expedite device replacements and issue clearer warnings

There is growing pressure from provincial health bodies and patient advocacy groups for stronger regulation of imported medical equipment, especially in light of the Philips situation.

What About ResMed?

As of now, no legal action has been filed against ResMed in Canada. While a 2023 safety notice raised concerns about some AirSense 10 units, no lawsuits or recalls have followed.

Consider Safer Options: BeC CPAP Machines

For Canadians still using recalled or questionable devices, litigation can be a slow path to justice. If you’re looking for a practical solution today, consider switching to BeC CPAP Machines, which have:

  • No recall history.
  • Full Health Canada compliance.
  • Complete setup packages (mask, hose, filters included).
  • Faster access and 20% lower costs than major brands.

Final Thought

Legal action offers one route to accountability, but it doesn’t help with sleep tonight. Stay informed, document everything, and if you’re ready for a safer option now, you don’t have to wait for the courts.

Next, we’ll look at what Canadian health agencies are saying about the risks associated with recalled CPAP machines.

What health agencies have weighed in on the CPAP recall risks?

Since the Philips CPAP recall first erupted in 2021, national and international health agencies have played a central role in evaluating, regulating, and communicating the risks tied to the affected devices. From Health Canada to the U.S. FDA, and extending to agencies in Europe and Asia, multiple authorities have investigated the safety of foam-degrading CPAP units — particularly those from Philips Respironics.

This section summarizes the key positions, warnings, and actions issued by major health agencies that are relevant to Canadian patients, and how their findings continue to shape public health guidance.

1. Health Canada: National Oversight and Ongoing Alerts

Health Canada is the primary agency responsible for monitoring medical device safety in Canada. Its response to the Philips recall includes:

  • Classifying the Philips recall as a Type I recall — the most serious level, indicating potential for severe health consequences or death.
  • Maintaining updated notices on the Recalls and Safety Alerts database.
  • Issuing multiple public health advisories to physicians, sleep clinics, and suppliers.
  • Coordinating with provincial regulators to ensure clinics inform patients with affected devices.
  • Recommending users do not stop therapy without medical advice, even if the device is recalled.

Health Canada continues to collect and analyze reports through its MedEffect program, encouraging patients to report symptoms possibly linked to degraded foam exposure.

2. U.S. Food and Drug Administration (FDA)

The U.S. FDA was the first agency to classify the Philips recall as a Class I recall, and has maintained that designation through 2025. Its findings include:

  • Confirming that PE-PUR foam used in Philips devices can degrade and release toxic particles and VOCs.
  • Citing risk of respiratory irritation, headaches, chemical exposure, and potential cancer.
  • Ordering Philips to submit more comprehensive post-market surveillance data.
  • Publishing test results that showed foam breakdown occurs even in normal environmental conditions, not just high heat or humidity.

The FDA also released a timeline of Philips’ internal knowledge of the risks, raising questions about manufacturer transparency.

3. European Medicines Agency (EMA) & Other International Bodies

While the FDA and Health Canada have led most investigations, other global agencies have weighed in:

  • The European Medicines Agency (EMA) issued a continent-wide alert to sleep centres and hospitals across the EU.
  • Agencies in Australia and Singapore launched recall verification programs to inspect imported Philips stock.
  • Some countries temporarily banned import or sales of the affected models until further safety testing could be completed.

These international responses further underscore the global scale and gravity of the Philips recall.

4. Canadian Thoracic Society & Sleep Medicine Specialists

Canadian professional bodies have also issued guidance:

  • The Canadian Thoracic Society (CTS) advised physicians to conduct individual risk assessments for each patient.
  • Some sleep labs in Ontario and Quebec have recommended switching patients to alternative machines where possible.
  • Sleep physicians are increasingly advising the use of recall-free options, like BeC CPAP Machines, to avoid uncertainty.

5. Canadian Provincial Health Authorities

Several provincial health departments have responded directly:

  • Ontario Health released a bulletin in 2024 encouraging clinics to proactively screen for recalled devices.
  • Alberta Health Services developed an online CPAP recall resource hub.
  • Some provinces have expanded insurance coverage to include devices replaced due to the recall.

Summary: What Does This Mean for Canadians?

  • Health Canada and the FDA agree: the foam degradation risk is real, and safety monitoring will continue well into 2025.
  • Canadian users should follow agency-backed steps: confirm device serial numbers, consult their physician, and report any symptoms.
  • Patients looking to switch should choose fully compliant, recall-free devices with a Canadian support network.

A Safer Path Forward: BeC CPAP Machines

While major agencies work to resolve the Philips recall aftermath, Canadian patients don’t have to wait.

BeC CPAP Machines are:

  • Fully compliant with Health Canada standards.
  • Never subject to recalls or safety notices.
  • Available across Canada with 20% savings compared to global brands.

Visit https://beccpap.ca to order your recall-free CPAP solution or connect with a clinic near you.

Next: We’ll explore what patients are saying in forums and support groups — and how that feedback reflects broader sentiment about the recall.

What do patients report in CPAP recall forums and support groups?

Since the Philips CPAP recall was announced in 2021, online forums and support groups — especially those catering to Canadian users — have become vital spaces for sharing firsthand experiences, concerns, frustrations, and solutions. While official reports from Health Canada and the FDA offer structured recall data, these patient-driven communities reveal the human side of the crisis.

Here’s what Canadian CPAP users are saying online, and how their stories reflect broader recall-related trends.

1. Frustration Over Long Replacement Delays

One of the most commonly voiced issues in forums like Reddit (r/SleepApnea), Apnea Board, and Facebook support groups is the months-long wait for replacement machines.

“Registered for a replacement DreamStation in August 2021. It’s now 2024, and I still haven’t received a new unit. I had to buy one out-of-pocket.”

Many Canadian users feel overshadowed by U.S.- based recall responses, noting that Canadian supply chains appear slower or deprioritized. Some report calling Philips or suppliers multiple times with little clarity on shipping timelines.

2. Health Concerns and Symptom Reports

Numerous forum posts and threads document users experiencing new or worsening symptoms, including:

  • Coughing and sore throats
  • Respiratory irritation or tight chest
  • Unusual smells coming from their device
  • Fatigue, headaches, and sinus issues

Some users only discovered their symptoms were likely linked to foam degradation after reading recall information online. Others shared that their physicians weren’t initially aware of the recall, underscoring a gap in public health communication.

“For months, I blamed my allergies. Turns out my recalled DreamStation was emitting VOCs. I wish I knew sooner.”

3. Emotional Strain and Anxiety

CPAP forums show that beyond physical symptoms, many users are experiencing high levels of stress and anxiety.

Concerns include:

  • Using a machine they now fear may be unsafe
  • Not being able to afford a new device out-of-pocket
  • Feeling dismissed by manufacturers or suppliers

This is especially true among older adults and those on fixed incomes, who rely on provincial funding or insurance to access sleep therapy.

“I’m a pensioner and can’t sleep without CPAP. But mine’s recalled, and I can’t afford to buy another. I feel stuck.”

4. Praise for Recall-Free Alternatives Like BeC CPAP

As frustration with Philips has grown, many users have shared positive experiences switching to alternative brands, including BeC CPAP Machines in Canada.

Reported benefits include:

  • Fast delivery, sometimes within 5–7 days.
  • Included accessories (mask, filters, tubing).
  • 20–25% lower cost than Philips or ResMed.

“Ordered a BeC CPAP machine after waiting over a year. Came fully set up and working great. No weird smells. Breathing clean again.”

Some groups have even created “safe CPAP lists” that highlight devices without a history of recalls or foam issues — BeC CPAP is often mentioned as a top choice.

5. Calls for Greater Transparency from Philips

Across almost every support platform, Canadian users have called for more transparent communication from Philips.

Complaints include:

  • Vague status updates during registration.
  • Lack of estimated timelines for replacements.
  • Inconsistent messaging from call centre staff.

Many patients have turned to forums for peer-led advice because official channels have proven slow or confusing.

“We shouldn’t have to piece together medical advice in Facebook groups. Philips and Health Canada owe us clear info.”

Where to Follow the Conversation

If you’re looking to connect with other Canadian CPAP users navigating the recall, here are some active communities:

Summary: What These Stories Reveal

Patient feedback from online groups highlights how the recall has affected more than just equipment — it’s affected lives.

Canadian users are demanding:

  • Faster communication.
  • Safer, more affordable machines.
  • Better support from suppliers and public agencies.

And many are choosing to take control by switching to recall-free options like BeC CPAP, proving that community knowledge can be a powerful form of advocacy.

Next: We’ll examine how the Philips recall is impacting the continuity of sleep apnea treatment in Canada — and what doctors are doing to help patients stay safe.

How does the Philips recall affect sleep apnea treatment continuity?

The Philips CPAP recall has not only disrupted equipment availability — it has directly impacted how Canadians manage their sleep apnea treatment. CPAP therapy is essential for individuals with moderate to severe obstructive sleep apnea (OSA), and any interruption, even short-term, can pose serious health risks. The recall has introduced a host of continuity challenges, from device shortages and treatment delays to patient anxiety and poor compliance.

Here’s how the recall is affecting treatment plans, what physicians are seeing, and how patients in Canada are adapting.

Why Treatment Continuity Matters for Sleep Apnea

Continuous Positive Airway Pressure (CPAP) therapy works by keeping the airway open throughout the night. 

For patients with diagnosed sleep apnea, missing even a few nights of treatment can lead to:

  • Daytime sleepiness and cognitive impairment.
  • Increased blood pressure.
  • Greater risk of heart attack or stroke.
  • Mood disorders and mental health decline.

For this reason, any disruption in device access — as caused by the Philips recall — poses real health consequences.

“I skipped two weeks while waiting for a new unit. By the second night, I was back to waking up gasping. It set my treatment back months.” — Jordan R., Victoria, BC

Delays in Replacements Mean Patients Go Without Therapy

Canadian patients who registered their recalled Philips units in 2021–2023 have reported wait times stretching into 12–24 months, with no definitive delivery date. 

The impact includes:

  • Abandoning therapy due to no alternative.
  • Switching to suboptimal treatments like mouth guards or positional therapy.
  • In some cases, reverting to untreated OSA, with symptoms worsening rapidly.

Sleep specialists across Canada have voiced concern about this prolonged interruption.

Clinics Are Overwhelmed and Out of Loaners

Many clinics and CPAP suppliers in Ontario, Alberta, and Quebec have run out of loaner units due to the sheer volume of affected users.

Sleep clinics are also reporting:

  • Staff burnout due to increased patient anxiety and complaints.
  • Increased demand for retesting and re-prescription as users seek new machines.
  • Backlogs in home sleep studies, as new patients can’t begin therapy until replacements arrive.

Lower Compliance, Higher Risk

Doctors note that recall-related stress has led to lower adherence. 

Patients who once followed nightly therapy routines now:

  • Use machines intermittently due to fear of foam exposure.
  • Sleep less overall due to anxiety.
  • Delay medical checkups or fail to track therapy metrics.

This can cause a domino effect of deteriorating health that goes beyond sleep apnea.

Impact on Newly Diagnosed Patients

The recall has also slowed down diagnosis-to-treatment timelines for new patients. Clinics are:

  • Unable to offer CPAP trials without enough equipment
  • Cautious about prescribing Philips devices unless replacements are guaranteed

This leaves newly diagnosed individuals in limbo, worsening symptoms while they wait for an initial machine.

“I finally got diagnosed but couldn’t start therapy — there was no CPAP left to loan. I waited three months to get started.”

How BeC CPAP Machines Are Filling the Gap

As Philips recall delays continue, many clinics and patients in Canada are turning to BeC CPAP Machines to maintain treatment continuity.

Key advantages include:

  • Immediate availability, even when global brands are backlogged.
  • 20% more affordable, especially for uninsured or underinsured patients.
  • No recall history, providing peace of mind.
  • Covered by many insurance and provincial health programs

Some sleep clinics now recommend BeC as a first-line therapy option, particularly when reliability and delivery speed are essential.

“BeC let me start therapy the same week I got diagnosed. That never would’ve happened with Philips or ResMed.” — Claire M., Ottawa

Tips for Protecting Your Treatment Plan

  1. Don’t stop therapy unless your doctor advises it.
  2. Ask your clinic about alternative brands like BeC CPAP.
  3. Track your symptoms and share with your provider.
  4. Contact your insurance to ask about replacement coverage or alternate funding.
  5. Use Health Canada’s site to stay informed.

Final Word

The Philips recall has had a disproportionate effect on sleep apnea treatment continuity across Canada. From missed nights of therapy to postponed diagnoses, the healthcare system — and patients — are still feeling the impact.

But help is available. With Canadian-made, recall-free options like BeC CPAP Machines, treatment doesn’t have to stop. It just needs to pivot.

Next: We’ll discuss whether it’s possible — or legal — to sell or donate a recalled CPAP machine in Canada.

Conclusion: What should CPAP users do now based on the latest recalls?

The CPAP landscape in Canada has shifted dramatically since the Philips recall in 2021, with consequences that are still rippling into 2025. Between ongoing legal actions, shifting medical guidelines, and rising patient frustration, it’s clear that Canadian CPAP users need reliable information and safer alternatives.

This conclusion summarizes what every user should now consider — based on Health Canada’s advisories, international health agency reports, legal trends, and real patient experiences.

1. Check Your CPAP Device Immediately

If you’re using a Philips Respironics device, verify whether it’s part of the recall by:

If you own a ResMed device, especially an AirSense 10, check for performance issues but note: no Canadian recall has been issued as of late 2025.

2. Don’t Stop Therapy Without Medical Guidance

Health Canada and the Canadian Thoracic Society both recommend:

  • Continuing CPAP use unless you experience symptoms or are explicitly told to stop.
  • Monitoring your health closely for irritation, coughing, or strange odours from your machine.
  • Consulting your sleep specialist if you’re unsure.

Untreated sleep apnea can lead to serious complications. Even if your machine is recalled, stopping therapy altogether can be more dangerous.

3. Document Your Case and Stay Informed

If you’re part of the Philips recall:

  • Keep all records of registration, symptoms, and correspondence with the company.
  • Follow the evolving class actions in Ontario, Quebec, and British Columbia.
  • Watch updates via Health Canada or MedEffect Canada.

Your documentation could be key in any future settlement.

4. Be Skeptical of Delays — Seek Recall-Free Alternatives

If you’ve been waiting months (or years) for a Philips replacement or feel uncertain about using older devices, consider alternatives that offer:

  • Immediate availability.
  • Full Health Canada compliance.
  • No history of recall or chemical exposure risks.

This is where many patients are turning to BeC CPAP Machines:

  • 20% more affordable than global brands.
  • Comes complete with tubing, mask, and filters.
  • Widely available across Canada.
  • Covered by many provincial plans and insurance providers.

“I waited two years for a replacement. Switching to BeC was the best decision for my health and peace of mind.” — Terry L., Calgary

5. Advocate for Better Standards

This recall crisis has shown gaps in:

  • Medical device oversight.
  • Recall communication.
  • Clinic capacity to manage replacement demands.

Patients and clinics alike can support:

  • Better transparency laws.
  • Stronger Health Canada enforcement.
  • More education for physicians on equipment risks.

Final Word

The CPAP recall has affected hundreds of thousands of users — not just in terms of equipment, but trust, health, and peace of mind. As we move forward into 2025, Canadian CPAP users have a choice:

  • Wait for uncertain timelines from recalled manufacturers
  • Or take control with a safe, reliable, Canadian-made alternative

BeC CPAP Machines offer that stability — with no recall history and a fully compliant setup ready to go.You don’t have to wait to breathe safely again.

Add to cart
Add to cart
Add to cart
Related Articles
long line in walk-IN clinic
Does OHIP cover CPAP machines?

If you’ve been diagnosed with sleep apnea in Ontario, one of your first questions might be: “Who pays for the machine that helps me breathe at night?” The answer involves two important programs: OHIP and the ADP program (Assistive Devices Program). But they serve different roles, and it’s crucial to understand what each covers.

Read More »
Ready to Check out our Products?

Just click below to check out the revolutionary BeC CPAP Machine and Masks.

Learn more about the BeC CPAP Machine!